Baktiar Hasan
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 17, 2021
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 07, 2020
Sample size computation in phase II designs combining the A'Hern design and the Sargent and Goldberg design.
Journal: Journal of biopharmaceutical statistics
Published: July 24, 2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 23, 2019
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 23, 2019
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 27, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 16, 2018
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 16, 2018
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 27, 2017
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer.
Journal: The pharmacogenomics journal
Published: July 11, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.
Journal: European journal of dermatology : EJD
Published: May 05, 2017
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.
Journal: Clinical lung cancer
Published: February 17, 2017
Last Updated: 09/26/2026